Every open market buy and sale of Vertex Pharmaceuticals Inc / MA stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $140M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when VRTX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an VRTX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every VRTX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sangeeta N. BhatiaDirector | Sale plan | 271 | $547.86 | $148K | 4,653 | Nov 18Form 4 |
| Nov 16, 2026 | Nancy ThornberryDirector | Sale plan | 1,000 | $547.86 | $548K | 1,109 | Nov 18Form 4 |
| Nov 12, 2026 | Charles F Wagner JrEvp, Co & Fo | Sale plan | 15,286 | $547.87 | $8.4M | 31,764 | Nov 16Form 4 |
| Nov 6, 2026 | Reshma KewalramaniCEO & President | Sale plan | 11,866 | $531.53 | $6.3M | 86,471 | Nov 10Form 4 |
| Jul 2, 2026 | Duncan McKechnieEVP, Chief Commercial Officer | Sale plan | 1,541 | $519.00 | $800K | 11,001 | Jul 7Form 4 |
| Jul 2, 2026 | Ourania TatsisEVP, Chief Reg. & Quality Off. | Sale plan | 1,500 | $524.99 | $787K | 45,321 | Jul 7Form 4 |
| Jul 1, 2026 | Joy LiuEVP and Chief Legal Officer | Sale plan | 828 | $502.71 | $416K | 19,131 | Jul 6Form 4 |
| Jun 26, 2026 | Carmen BozicEVP and CMO | Sale plan | 596 | $482.50 | $288K | 15,337 | Jun 30Form 4 |
| Jun 18, 2026 | Carmen BozicEVP and CMO | Sale plan | 1,020 | $462.17 | $471K | 15,933 | Jun 23Form 4 |
| Jun 15, 2026 | Carmen BozicEVP and CMO | Sale plan | 4,062 | $450.00 | $1.8M | 16,953 | Jun 17Form 4 |
| Jun 5, 2026 | Carmen BozicEVP and CMO | Sale plan | 1,745 | $450.00 | $785K | 21,015 | Jun 9Form 4 |
| Jun 1, 2026 | Joy LiuEVP and Chief Legal Officer | Sale plan | 828 | $439.91 | $364K | 19,959 | Jun 3Form 4 |
| May 29, 2026 | Carmen BozicEVP and CMO | Sale plan | 1,974 | $450.00 | $888K | 22,760 | Jun 2Form 4 |
| May 15, 2026 | Carmen BozicEVP and CMO | Sale plan | 1,354 | $453.45 | $614K | 24,734 | May 19Form 4 |
| May 15, 2026 | Mark E. BunnageEVP, Chief Scientific Officer | Sale plan | 33 | $453.45 | $15K | 7,284 | May 19Form 4 |
VRTX insider trading FAQ
Are VRTX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of VRTX on the open market in 0 trades, and 14 sold $140M in 54 trades, 100% of that under pre-arranged trading plans.
When did an VRTX insider last buy shares?
Bruce I Sachs (Director) bought 5,000 shares for $1.9M on Aug 6, 2025, reported on Aug 7, 2025.
When did an VRTX insider last sell shares?
Sangeeta N. Bhatia (Director) sold 271 shares for $148K on Nov 16, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
